Who owns NEUROSENSE THERAPEUTICS LTD?

Tip: Access positions for across all investors

Analyze quarterly positions in Neurosense Therapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Neurosense Therapeutics stock

Who bought or sold NEUROSENSE THERAPEUTICS LTD this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Armistice Capital 662k $470k -48% Sep 2023
 View chart
Meitav Dash Investments 95k $75k 0% Dec 2023
 View chart
Hrt Financial 14k $10k 100% Dec 2023
 View chart
UBS Group 5.5k $4.3k -43% Dec 2023
 View chart
CWM 1.0k $1.0k 0% Dec 2023
 View chart

Who sold out of Neurosense Therapeutics?

Fund or Company Name Date Sold Shares Held Valued At
Citadel Advisors Sep 2023 12k $8.8k